News About <![CDATA[Christopher & Banks Corp.]]> News About en-us <![CDATA[68.5% Return Seen to Date on SmarTrend Christopher & Banks Call (CBK)]]> <![CDATA[Bankers push for Italian SME-backed covered bonds]]> <![CDATA[Europe banks hesitate to join rush for new share capital]]> <![CDATA[Christopher & Banks: The Winning Streak Continues (CBK)]]> <![CDATA[Market Chatter-Corporate finance press digest]]> <![CDATA[UPDATE 1-Commerzbank sets terms for $3.3 bln capital hike]]> <![CDATA[US STOCKS-Futures dip after record high; retail sales on tap]]> <![CDATA[Christopher & Banks Corporation Announces Termination of Share Rights Plan]]> <![CDATA[Updates, advisories and surprises]]> <![CDATA[Costs centre stage for HSBC, French bank results]]> <![CDATA[Christopher & Banks Up 51.3% Since SmarTrend Uptrend Call (CBK)]]> <![CDATA[UPDATE 1-UK leasing firms in government talks over FLS credit scheme]]> <![CDATA[Market Chatter-Corporate finance press digest]]> <![CDATA[PRESS DIGEST - Financial Times - April 18]]> <![CDATA[Commerzbank closing in on 4-bln-stg Eurohypo deal - report]]> <![CDATA[UPDATE 1-Deutsche Bank caps co-CEOs 2013 pay at 9.85 mln euros]]> <![CDATA[Christopher & Banks Has Returned 43.2% Since SmarTrend Recommendation (CBK)]]> <![CDATA[German stocks - Factors to watch on April 4]]> <![CDATA[Uptrend Call Working As Christopher & Banks Stock Rises 32.8% (CBK)]]> <![CDATA[Christopher & Banks Shares Up 38.1% Since SmarTrend's Buy Recommendation (CBK)]]> <![CDATA[INSIGHT-German reliance on Deutsche Bank outweighs scandals]]> <![CDATA[UPDATE 2-EU includes ISDA in credit derivatives investigation]]> <![CDATA[Credit Agricole shows challenges for mid-tier investment bank players]]> <![CDATA[This Fading Retailer Is Ripe for a Short]]> ]]> <![CDATA[Deutsche Bank braced for $390 mln Iran sanctions charges-report]]> <![CDATA[MOVES-Bank Of America Merrill Lynch, Commerzbank, Brewin Dolphin]]> <![CDATA[Christopher & Banks Up 41.9% Since SmarTrend Uptrend Call (CBK)]]> <![CDATA[Germany's Osram gains 1.25 bln euro funding ahead of spin-off]]> <![CDATA[Bullish Moving Average Cross by Christopher & Banks (CBK)]]> <![CDATA[Trending Apparel Stores Stocks - The Men's Wearhouse (MW), Chico's FAS (CHS), Christopher & Banks (CBK)]]> New York, NY -- (SBWIRE) -- 03/15/2013 -- StockRunway.com issues special report on the Trending Apparel Stores Stocks – The Men's Wearhouse, Inc (NYSE:MW), Chico's FAS, Inc (NYSE:CHS), Christopher & Banks Corporation (NYSE:CBK)

]]>
<![CDATA[Trending Apparel Stores Stocks - The Men's Wearhouse (MW), Chico's FAS (CHS), Christopher & Banks (CBK)]]> <![CDATA[Stocks in News: Christopher & Banks Corporation, CKX Lands Inc, Rockwell Collins, PROS Holdings]]> Lakeway, TX -- (SBWIRE) -- 03/14/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

]]>
<![CDATA[Coldwater, Christopher & Banks make headway]]> <![CDATA[Hot Stocks in Focus: Christopher & Banks, Arcos Dorados Holding, Aruba Networks, Bright Horizons Family Solutions]]> Lakeway, NY -- (SBWIRE) -- 03/14/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

]]>
<![CDATA[UPDATE: Piper Jaffray Raises PT to $9 on Christopher & Banks on Q1 Comps Outlook]]> Piper Jaffray maintained Christopher & Banks (NYSE: CBK) with an Overweight rating and raised the price target from $6.00 to $9.00.

Piper Jaffray analyst Neely J.N. Tamminga noted, "We are reiterating our Overweight rating on CBK shares on the heels of the company's FQ4 release and early indications that

]]>
<![CDATA[Sucampo Pharmaceuticals, Christopher & Banks Announce Earnings]]> <![CDATA[Sidoti Upgrades Christopher & Banks (CBK) to Buy]]> <![CDATA[Christopher & Banks Rising on Above-Average Volume, Consistent With Trend (CBK)]]> <![CDATA[Early Movers: AMZN, KO, MW & More]]> <![CDATA[Christopher & Banks Corp. (CBK) Tops Q4 EPS by 29c, 18.5% Increase in Comps]]> <![CDATA[BRIEF-Christopher and Banks up in extended trading]]> <![CDATA[Christopher & Banks Corporation Reports Results for the Fourteen and Fifty-Three Week Periods Ended February 2, 2013]]> <![CDATA[Stocks Recap: Caesars Entertainment Corp, Engility Holdings Inc, Christopher & Banks Corporation, Netflix]]> Lakeway, TX -- (SBWIRE) -- 03/13/2013 -- vbtrendreport.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks.

]]>
<![CDATA[Christopher & Banks Has Returned 52.2% Since SmarTrend Recommendation (CBK)]]> <![CDATA[Recent 52-Week High Exceeded in Shares of Christopher & Banks (CBK)]]> <![CDATA[Dougherty & Co Starts Christopher & Banks (CBK) at Buy]]> <![CDATA[Wall Street Pre-Market Report]]> <![CDATA[Earnings Scheduled For March 13, 2013]]> Accretive Health (NYSE: AH) is expected to report its Q4 earnings at $0.09 per share on revenue of $236.87 million.

Elbit Systems (NASDAQ: ESLT) is estimated to report its Q4 earnings at $0.88 per share on revenue of $838.40 million.

Discovery Laboratories (NASDAQ: DSCO) is projected

]]>
<![CDATA[Market Chatter-Corporate finance press digest]]> <![CDATA[Market Chatter-Corporate finance press digest]]>